DOCSLIB.ORG

The 360 Terms Named for 431 People in First Aid for the USMLE Step 11 (2019)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The 360 Terms Named for 431 People in First Aid for the USMLE Step 11 (2019) Supplemental Digital Content for The Gender Gap in Medical Eponyms: A USMLE Step 1 Content Analysis. Acad Med. Supplemental Digital Appendix 1 1 The 360 Terms Named for 431 People in First Aid for the USMLE Step 1 (2019) 1. Addison disease 57. Cahill cycle 113. Felty syndrome 2. Albright osteodystrophy 58. Call*/Exner bodies 114. Fick principle 3. Alport syndrome 59. Caplan syndrome 115. Fitz-Hugh/Curtis syndrome 4. Alzheimer disease 60. Casal necklace 116. Friedreich ataxia 5. Angelman syndrome 61. Chagas disease 117. Galant reflex 6. Anitschkow cells 62. Charcot/Bouchard microaneurysm 118. Great vein of Galen 7. Apgar* score 63. Charcot/Leyden crystals 119. Gardner syndrome 8. Argyll Robertson pupil 64. Charcot/Marie/Tooth disease 120. Gartner duct 9. Arthus reaction 65. Chédiak/Higashi syndrome 121. Gaucher disease 10. Aschoff bodies 66. Cheyne/Stokes respirations 122. Gaussian distribution 11. Asherman syndrome 67. Chiari malformation 123. Ghon complex 12. Asperger syndrome 68. Churg/Strauss* syndrome 124. Giemsa stain 13. Auer rods 69. Chvostek sign 125. Gilbert syndrome 14. Auerbach plexus 70. Clara cells 126. Gitelman syndrome 15. Auspitz sign 71. Codman triangle 127. Glanzmann thrombasthenia 16. Babesiosis 72. Colles fracture 128. Golgi apparatus 17. Babinski reflex 73. Conn syndrome 129. Good syndrome 18. Bachmann bundle 74. Coombs test 130. Goodpasture syndrome 19. Baker cyst 75. Cori/Cori* disease 131. Gottron papules 20. Barlow maneuver 76. Councilman bodies 132. Gower sign 21. Barr bodies 77. Courvoisier sign 133. Gram stain 22. Barrett esophagus 78. Cowdry bodies 134. Graves disease 23. Bartholin cyst/abscess 79. Cowper gland 135. Guillain/Barré syndrome 24. Bartter syndrome 80. Creutzfeldt/Jakob disease 136. Guyon canal 25. Beck triad 81. Crigler/Najjar syndrome 137. Hamman sign 26. Becker muscular dystrophy 82. Crohn disease 138. Hansen disease 27. Beckwith/Wiedemann syndrome 83. Curling ulcer 139. Hardy/Weinberg genetics 28. Beers criteria 84. Curschmann spirals 140. Hartnup disease 29. Behçet syndrome 85. Cushing syndrome/disease 141. Hashimoto thyroiditis 30. Bell palsy 86. Dandy/Walker syndrome 142. Hassall corpuscles 31. Bence Jones protein 87. de Quervain thyroiditis 143. Heberden nodes 32. Berger disease 88. Denys/Drash syndrome 144. Heinz bodies 33. Berkson bias 89. Diamond/Blackfan anemia 145. Henderson/Hasselbalch equation 34. Bernard/Soulier syndrome 90. Space of Disse 146. Loop of Henle 35. Birbeck granules 91. Donovanosis 147. Henoch/Schönlein purpura 36. Bitot spot 92. Down syndrome 148. Hesselbach triangle 37. Blumer shelf 93. Dressler syndrome 149. Hirschsprung disease 38. Boerhaave syndrome 94. Dubin/Johnson syndrome 150. Bundle of His 39. Bohr effect 95. Duchenne muscular dystrophy 151. Hodgkin lymphoma 40. Bordet/Gengou agar 96. Dupuytren contracture 152. Homer Wright rosettes/stain 41. Bouchard nodes 97. Duret hemorrhage 153. Horner syndrome 42. Bowen disease 98. Eaton agar 154. Howell/Jolly bodies 43. Bowman capsule 99. Ebstein anomaly 155. Hunter syndrome 44. Brenner tumor 100. Edinger/Westphal nuclei 156. Huntington disease 45. Broca's area 101. Edwards syndrome 157. Hurler* syndrome 46. Brown-Séquard syndrome 102. Ehlers/Danlos syndrome 158. Hurthle cells 47. Brucellosis 103. Ehrlichiosis 159. Hutchinson teeth 48. Brugada syndrome 104. Eisenmenger syndrome 160. Janeway lesions 49. Brunner glands 105. Elek test 161. Jarisch/Herxheimer reaction 50. Brushfield spots 106. Epley maneuver 162. Jervell/Lange-Nielsen syndrome 51. Bruton agammaglobulinemia 107. Epstein*/Barr virus 163. Jod-Basedow phenomenon 52. Fascia of Buck 108. Erb palsy 164. Kallmann syndrome 53. Budd/Chiari syndrome 109. Ewing sarcoma 165. Kaposi sarcoma 54. Buerger disease 110. Fabry disease 166. Kartagener syndrome 55. Burkitt lymphoma 111. Tetralogy of Fallot 167. Kawasaki disease 56. Burton lines 112. Fanconi anemia 168. Kayser/Fleischer rings Copyright © by the Association of American Medical Colleges. Unauthorized reproduction is prohibited. Supplemental Digital Content for The Gender Gap in Medical Eponyms: A USMLE Step 1 Content Analysis. Acad Med. 169. Kegel exercise 231. Foramen of Monro 293. Roth spots 170. Bundle of Kent 232. Müllerian duct 294. Rotor syndrome 171. Kernohan notch 233. Murphy sign 295. Rovsing sign 172. Kiesselbach plexus 234. Negri bodies 296. Ruffini corpuscles 173. Killian triangle 235. Nelson syndrome 297. Russell sign 174. Kimmelstiel/Wilson nodules 236. Niemann/Pick disease 298. Sabin vaccine 175. Klinefelter syndrome 237. Nikolsky sign 299. Salk vaccine 176. Klumpke* palsy 238. Nissl bodies/substance 300. Schaumann bodies 177. Klüver/Bucy syndrome 239. Sphincter of Oddi 301. Schatzki bodies 178. Korsakoff syndrome 240. Okazaki/Okazaki* fragments 302. Schiller/Duval bodies 179. Krabbe disease 241. Osgood/Schlatter disease 303. Schilling test 180. Krebs cycle 242. Osler/Weber/Rendu syndrome 304. Schüffner stippling 181. Krukenberg tumor 243. Pacinian corpuscles 305. Schwann cells 182. Kübler-Ross* model 244. Paget disease 306. Sertoli cell 183. Kulchitsky cells 245. Pancoast tumor 307. Sézary syndrome 184. Kupffer cells 246. Papanikolaou smear 308. Sheehan syndrome 185. Kussmaul sign 247. Pappenheimer bodies 309. Sjögren syndrome 186. Lambert/Eaton syndrome 248. Parinaud syndrome 310. Starling forces 187. Langerhans islets/histiocytosis 249. Parkinson disease 311. Stevens/Johnson syndrome 188. Laplace law 250. Patau syndrome 312. Sturge/Weber syndrome 189. Laron syndrome 251. Pautrier microabscesses 313. Swan/Ganz catheter 190. Leber optic neuropathy 252. Pavlovian conditioning 314. Sydenham chorea 191. Legg/Calvé/Perthes disease 253. Pearson correlation coefficient 315. Sylvian fissure/aqueduct 192. Leishmaniasis 254. Pseudo-Pelger/Huet anomaly 316. Takayasu arteritis 193. Lesch/Nyhan syndrome 255. Periodic acid-Schiff stain 317. Tamm/Horsfall mucoprotein 194. Leser/Trélat sign 256. Perls Prussian blue stain 318. Tay/Sachs disease 195. Lewy bodies 257. Peutz/Jeghers syndrome 319. Thayer/Martin agar 196. Leydig cell 258. Peyer patches 320. Tourette syndrome 197. Li/Fraumeni syndrome 259. Peyronie disease 321. Treacher Collins syndrome 198. Libman/Sacks endocarditis 260. Phalen maneuver 322. Trendelenburg gait 199. Liddle syndrome 261. Pick disease 323. Trousseau sign 200. Crypts of Lieberkühn 262. Pierre Robin sequence 324. Turcot syndrome 201. Light criteria 263. Plummer/Vinson syndrome 325. Turner syndrome 202. Lineweaver/Burk plot 264. Pompe disease 326. Tzanck test 203. Lisch nodules 265. Pott disease 327. Ampulla of Vater 204. Listeriosis 266. Potter* sequence 328. Virchow nodes 205. Loffler endocarditis/medium 267. Prader/Willi syndrome 329. Von Gierke disease 206. Foramen of Luschka 268. Prehn sign 330. Von Hippel/Lindau disease 207. Lynch syndrome 269. Prinzmetal angina 331. Von Recklinghausen disease 208. MacConkey Agar 270. Purkinje cells 332. Von Willebrand disease 209. Foramen of Magendie 271. Erythroplasia of Queyrat 333. Waldenström macroglobulinemia 210. Mallory/Weiss syndrome 272. Ramsay Hunt syndrome 334. Wallerian degeneration 211. Marcus Gunn pupils 273. Nodes of Ranvier 335. Warburg effect 212. Marfan syndrome 274. Rathke pouch 336. Warthin tumors 213. Mayer/Rokitansky/Küster/ 275. Raynaud phenomenon 337. Waterhouse/Friderichsen 214. Hauser syndrome 276. Reed*/Sternberg cells syndrome 215. McArdle disease 277. Reichert cartilage 338. Weber test 216. McBurney point/sign 278. Reid* index 339. Wegener granulomatosis 217. McCune/Albright syndrome 279. Reinke crystals 340. Weibel/Palade bodies 218. McMurray test 280. Reiter syndrome 341. Weil disease 219. Meckel diverticulum 281. Renshaw cells 342. Werdnig/Hoffmann disease 220. Meigs syndrome 282. Rett syndrome 343. Wernicke/Korsakoff syndrome 221. Meissner plexus/corpuscles 283. Reye syndrome 344. Wharton duct 222. Ménétrier disease 284. Richter transformation 345. Whipple disease 223. Ménière disease 285. Rickettsiosis 346. Wickham striae 224. Menkes disease 286. Riedel thyroiditis 347. Williams syndrome 225. Merkel discs 287. Rinne test 348. Circle of Willis 226. Meyer loop 288. Robertsonian translocation 349. Wilms tumors 227. Basal nucleus of Meynert 289. Romaña sign 350. Wilson disease 228. Michaelis/Menten* kinetics 290. Romano/Ward syndrome 351. Epiploic foramen of Winslow 229. Mobitz (Wenckebach) AV block 291. Romberg sign 352. Wiskott/Aldrich syndrome 230. Mönckeberg sclerosis 292. Rosenthal fibers 353. Wolffian duct Copyright © by the Association of American Medical Colleges. Unauthorized reproduction is prohibited. Supplemental Digital Content for The Gender Gap in Medical Eponyms: A USMLE Step 1 Content Analysis. Acad Med. 354. Wolff/Chaikoff effect 358. Zenker diverticulum 355. Wolff/Parkinson/White syndrome 359. Ziehl/Neelsen stain *Female 356. Lines of Zahn 360. Zollinger/Ellison syndrome 357. Zellweger syndrome References 1. Le T, Bhushan V. First Aid for the USMLE Step 1 2019. New York, NY: McGraw Hill Education; 2019. Copyright © by the Association of American Medical Colleges. Unauthorized reproduction is prohibited. .
Load more

Recommended publications
  • Physical Esxam
    Pearls in the Musculoskeletal Exam Frank Caruso MPS, PA-C, EMT-P Skin, Bones, Hearts & Private Parts 2019 Examination Key Points • Area that needs to be examined, gown your patients - well exposed • Understand normal functional anatomy • Observe normal activity • Palpation • Range of Motion • Strength/neuro-vascular assessment • Special Tests General Exam Musculoskeletal Overview Physical Exam Preview Watch Your Patients Walk!! Inspection • Posture – Erectness – Symmetry – Alignment • Skin and subcutaneous tissues – Swelling – Redness – Masses Inspection • Extremities – Size – Deformities – Enlargement – Alignment – Contour – Symmetry Inspection • Muscles – Bilateral symmetry – Hypertrophy – Atrophy – Fasciculations – Spasms Palpation • Palpate bones, joints, and surrounding muscles for the following: – Heat – Tenderness – Swelling – Fluctuation – Crepitus – Resistance to pressure – Muscle tone Muscles • Size and strength affected by the following: – Genetics – Exercise – Nutrition • Muscles move joints through range of motion (ROM). Muscle Strength • Compare bilateral muscles – Strength – Symmetry – Equality – Resistance End Feel Think About It!! • The sensation the examiner feels in the joint as it reaches the end of the range of motion of each passive movement • Bone to bone: This is hard, unyielding – normal would be elbow extension. • Soft–tissue approximation: yielding compression that stops further movement – elbow and knee flexion. End Feel • Tissue stretch: hard – springy type of movement with a slight give – toward the end of range of motion – most common type of normal end feel : knee extension and metacarpophalangeal joint extension. Abnormal End Feel • Muscle spasm: invoked by movement with a sudden dramatic arrest of movement often accompanied by pain - sudden hard – “vibrant twang” • Capsular: Similar to tissue stretch but it does not occur where one would expect – range of motion usually reduced.
    [Show full text]
  • The Hematological Complications of Alcoholism
    The Hematological Complications of Alcoholism HAROLD S. BALLARD, M.D. Alcohol has numerous adverse effects on the various types of blood cells and their functions. For example, heavy alcohol consumption can cause generalized suppression of blood cell production and the production of structurally abnormal blood cell precursors that cannot mature into functional cells. Alcoholics frequently have defective red blood cells that are destroyed prematurely, possibly resulting in anemia. Alcohol also interferes with the production and function of white blood cells, especially those that defend the body against invading bacteria. Consequently, alcoholics frequently suffer from bacterial infections. Finally, alcohol adversely affects the platelets and other components of the blood-clotting system. Heavy alcohol consumption thus may increase the drinker’s risk of suffering a stroke. KEY WORDS: adverse drug effect; AODE (alcohol and other drug effects); blood function; cell growth and differentiation; erythrocytes; leukocytes; platelets; plasma proteins; bone marrow; anemia; blood coagulation; thrombocytopenia; fibrinolysis; macrophage; monocyte; stroke; bacterial disease; literature review eople who abuse alcohol1 are at both direct and indirect. The direct in the number and function of WBC’s risk for numerous alcohol-related consequences of excessive alcohol increases the drinker’s risk of serious Pmedical complications, includ- consumption include toxic effects on infection, and impaired platelet produc- ing those affecting the blood (i.e., the the bone marrow; the blood cell pre- tion and function interfere with blood cursors; and the mature red blood blood cells as well as proteins present clotting, leading to symptoms ranging in the blood plasma) and the bone cells (RBC’s), white blood cells from a simple nosebleed to bleeding in marrow, where the blood cells are (WBC’s), and platelets.
    [Show full text]
  • Hematology Unit Lab 1 Review Material
    Hematology Unit Lab 1 Review Material Objectives Laboratory instructors: 1. Facilitate lab discussion and answer questions Students: 1. Review the introductory material below 2. Study and review the assigned cases and questions in small groups before the Lab. This includes the pathological material using Virtual Microscopy 3. Be prepared to present your cases, questions and answers to the rest of your Lab class during the Lab Erythropoiesis: The process of red blood cell (RBC) production • Characterized by: − Increasing hemoglobin synthesis Erythroid maturation stages (Below): − Decreasing cell size - Average of 4 cell divisions during maturation − Decreasing cytoplasmic basophilia [One pronormoblast gives rise to 16 red cells] (increasing pink color) - pronormoblast → reticulocyte = 7 days − Progressive chromatin condensation of the - reticulocytes → mature RBC =1-2 days nuclei − Extrusion of nucleus (orthochromatic stage) − Extruded nuclei are subsequently phagocytized − Loss of mitotic capability after the early stage of polychromatophilic normoblast • Picture below: Erythroid progenitors (normoblasts) cluster around macrophages (arrows) in the bone marrow and spleen • Macrophages store iron • Iron is transferred from macrophages to erythroid precursor cells • Iron is used by normoblasts for hemoglobin synthesis aka nucleated rbc aka reticulocyte 1 Mature Red Blood Cell 7-8 microns; round / ovoid biconcave disc with orange-red cytoplasm, no RNA, no nucleus; survives ~120 days in circulation Classification of Anemia by Morphology 1.
    [Show full text]
  • Abdomen and Superficial Structures Including Introductory Pediatric and Musculoskeletal
    National Education Curriculum Specialty Curricula Abdomen and Superficial Structures Including Introductory Pediatric and Musculoskeletal Abdomen and Superficial Structures Including Introductory Pediatric and Musculoskeletal Table of Contents Section I: Biliary ........................................................................................................................................................ 3 Section II: Liver ....................................................................................................................................................... 19 Section III: Pancreas ............................................................................................................................................... 35 Section IV: Renal and Lower Urinary Tract ........................................................................................................ 43 Section V: Spleen ..................................................................................................................................................... 67 Section VI: Adrenal ................................................................................................................................................. 75 Section VII: Abdominal Vasculature ..................................................................................................................... 81 Section VIII: Gastrointestinal Tract (GI) .............................................................................................................. 91
    [Show full text]
  • Complete Blood Count in Primary Care
    Complete Blood Count in Primary Care bpac nz better medicine Editorial Team bpacnz Tony Fraser 10 George Street Professor Murray Tilyard PO Box 6032, Dunedin Clinical Advisory Group phone 03 477 5418 Dr Dave Colquhoun Michele Cray free fax 0800 bpac nz Dr Rosemary Ikram www.bpac.org.nz Dr Peter Jensen Dr Cam Kyle Dr Chris Leathart Dr Lynn McBain Associate Professor Jim Reid Dr David Reith Professor Murray Tilyard Programme Development Team Noni Allison Rachael Clarke Rebecca Didham Terry Ehau Peter Ellison Dr Malcolm Kendall-Smith Dr Anne Marie Tangney Dr Trevor Walker Dr Sharyn Willis Dave Woods Report Development Team Justine Broadley Todd Gillies Lana Johnson Web Gordon Smith Design Michael Crawford Management and Administration Kaye Baldwin Tony Fraser Kyla Letman Professor Murray Tilyard Distribution Zane Lindon Lyn Thomlinson Colleen Witchall All information is intended for use by competent health care professionals and should be utilised in conjunction with © May 2008 pertinent clinical data. Contents Key points/purpose 2 Introduction 2 Background ▪ Haematopoiesis - Cell development 3 ▪ Limitations of reference ranges for the CBC 4 ▪ Borderline abnormal results must be interpreted in clinical context 4 ▪ History and clinical examination 4 White Cells ▪ Neutrophils 5 ▪ Lymphocytes 9 ▪ Monocytes 11 ▪ Basophils 12 ▪ Eosinophils 12 ▪ Platelets 13 Haemoglobin and red cell indices ▪ Low haemoglobin 15 ▪ Microcytic anaemia 15 ▪ Normocytic anaemia 16 ▪ Macrocytic anaemia 17 ▪ High haemoglobin 17 ▪ Other red cell indices 18 Summary Table 19 Glossary 20 This resource is a consensus document, developed with haematology and general practice input. We would like to thank: Dr Liam Fernyhough, Haematologist, Canterbury Health Laboratories Dr Chris Leathart, GP, Christchurch Dr Edward Theakston, Haematologist, Diagnostic Medlab Ltd We would like to acknowledge their advice, expertise and valuable feedback on this document.
    [Show full text]
  • Laboratory Diagnosis Review
    Laboratory Diagnosis Review Hematology Definition: The study of the three cellular elements of blood: Red Blood Cells (RBCs), White Blood Cells (WBCs), and Platelets Hemoglobin (Hgb or Hb): The oxygen carrying compound in RBCs Reference Range: Men 14-18 g/dL, Women 12-16 g/dL, Boy and girl levels are equal till age 11 Smoking increases, Pregnancy decreases, Capillary levels in newborns are higher than venous levels, Race, Position, and Time of day have minor effects, High WBCs may falsely raise Hgb. Below normal Hgb = anemia Red Blood Cell Count Reference Range: Men 4l5-6 million / cubic ml, Women4.0-5.5 million / ml3. Hematocrit (Hct): The ratio of RBCs to plasma Reference Range, Men 40%-54%, Women 37%-47%, Depends mostly on the number of RBCs but is slightly effected by the average RBC size, Not measured directly, but is calculated from the RBC count and the mean corpuscular volume (MCV). Increased by smoking, Decrease = anemia Useful Relationships: Hb X 3 = Hct RBCs (millions) X 3 = Hgb RBCs (millions) X 9 = Hct Wintrobe Indices: These indices are only significant if the RBCs, Hgb, and/or Hct. is abnormal MCV: Mean Corpuscular Volume MCH: Mean Corpuscular Hemoglobin MCHC: Mean Corpuscular Hemoglobin Concentration RDW: Red blood cell Distribution Width MCV: Reference Ranges: Men 80-95 fl (femtoliters), Women 81-99 fl (femto = 1 quadrillionth) Increased MCV = Macrocytosis, Decreased = Microcytosis MCV is increased by smoking, by B12 and/or folic acid deficiency, chronic liver disease, chronic alcoholism, Cardiorespiratory problems… Some macrocytic patients will not have macrocytosis MCV is decreased by iron deficiency, thalassemia, and anemia of chronic disease MCH: Reference Range 27-31 pg MCH is increased by Macrocytic anemias.
    [Show full text]
  • 10 11 Cyto Slides 81-85
    NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TESTING PROGRAM Glass Slide Critique ~ November 2010 Slide 081 Diagnosis: MDS to AML 9 WBC 51.0 x 10 /L 12 Available data: RBC 3.39 x 10 /L 72 year-old female Hemoglobin 9.6 g/dL Hematocrit 29.1 % MCV 86.0 fL Platelet count 16 x 109 /L The significant finding in this case of Acute Myelogenous Leukemia (AML) was the presence of many blast forms. The participant median for blasts, all types was 88. The blast cells in this case (Image 081) are large, irregular in shape and contain large prominent nucleoli. It is difficult to identify a blast cell as a myeloblast without the presence of an Auer rod in the cytoplasm. Auer rods were reported by three participants. Two systems are used to classify AML into subtypes, the French- American-British (FAB) and the World Health Organization (WHO). Most are familiar with the FAB classification. The WHO classification system takes into consideration prognostic factors in classifying AML. These factors include cytogenetic test results, patient’s age, white blood cell count, pre-existing blood disorders and a history of treatment with chemotherapy and/or radiation therapy for a prior cancer. The platelet count in this case was 16,000. Reduced number of platelets was correctly reported by 346 (94%) of participants. Approximately eight percent of participants commented that the red blood cells in this case were difficult to evaluate due to the presence of a bluish hue around the red blood cells. Comments received included, “On slide 081 the morphology was difficult to evaluate since there was a large amount of protein surrounding RBC’s”, “Slide 081 unable to distinguish red cell morphology due to protein” and “Unable to adequately assess morphology on slide 081 due to poor stain”.
    [Show full text]
  • Advanced Blood Cell Id: Peripheral Blood Findings in Sickle Cell Anemia
    ADVANCED BLOOD CELL ID: PERIPHERAL BLOOD FINDINGS IN SICKLE CELL ANEMIA Educational commentary is provided for participants enrolled in program #259- Advanced Blood Cell Identification. This virtual blood cell identification program includes case studies with more difficult challenges. To view the blood cell images in more detail, click on the sample identification numbers underlined in the paragraphs below. This will open a virtual image of the selected cell and the surrounding fields. If the image opens in the same window as the commentary, saving the commentary PDF and opening it outside your browser will allow you to switch between the commentary and the images more easily. Click on this link for the API ImageViewerTM Instructions. Learning Outcomes After completing this exercise, participants should be able to: • describe morphologic features of normal peripheral blood leukocytes. • identify morphologic characteristics distinctive of sickle cells. • distinguish selected RBC inclusions based on morphologic features. • describe significant morphologic characteristics of nucleated red blood cells. Case Study The CBC from a 30 year old African American male is as follows: WBC=9.5 x 109/L, RBC=1.66 x 1012/L, Hgb=5.0 g/dL, Hct=13.9%, MCV=83.7 fL, MCH=30.1 pg, MCHC=36.0 g/dL, RDW-CV=24.9%, MPV=9.6 fL, Platelet=326 x 109/L. Educational Commentary The cells and RBC inclusions chosen for identification in this testing event were seen in the peripheral blood of a man with a severe anemia resulting from sickle cell disease. The cell shown in ABI-08 contains a Howell-Jolly body.
    [Show full text]
  • Screening for Developmental Dysplasia of the Hip
    Screening for Developmental Dysplasia of the Hip: A Systematic Literature Review for the U.S. Preventive Services Task Force Scott A. Shipman, MD, MPH1 Mark Helfand, MD, MPH2 Virginia A. Moyer, MD, MPH3 Barbara P. Yawn, MD, MSc4 1Department of Pediatrics, and 2Oregon Evidence-based Practice Center, Oregon Health & Science University, Portland Ore 3Department of Pediatrics, University of Texas-Houston Health Science Center, Houston TX 4Department of Primary Care Research, Olmsted Medical Center, Rochester Minn Corresponding author: Scott A. Shipman, MD, MPH Department of Pediatrics Oregon Health & Science University 707 SW Gaines Rd., CDRC-P Portland, OR 97239 Phone: (503) 494-6542 FAX: (503) 494-4953 Email: [email protected] Abstract Background: Developmental dysplasia of the hip (DDH) represents a spectrum of anatomic abnormalities that can result in permanent disability. Objective: We sought to gather and synthesize the published evidence regarding screening for DDH by primary care providers. Methods: We performed a systematic review of the literature using a best evidence approach as used by the U.S. Preventive Services Task Force. The review focused on screening relevant to primary care in infants from birth to 6 months of age, and on interventions employed before 1 year of age. Results: The literature on screening and interventions for DDH suffers from significant methodological shortcomings. No published trials directly link screening to improved functional outcomes. Clinical examination and ultrasound identify somewhat different groups of newborns at risk for DDH. A significant proportion of hip abnormalities identified through clinical examination or ultrasound in the newborn period will spontaneously resolve. Very few studies examine the functional outcomes of patients who have undergone therapy for DDH.
    [Show full text]
  • Morphologic Evaluation of Anemia – I Adewoyin S
    nd M y a ed g ic lo i o n i e B Adewoyin and Ogbenna, Biol Med (Aligarh) 2016, 8:6 DOI: 10.4172/0974-8369.1000322 ISSN: 0974-8369 Biology and Medicine Review Article Open Access Morphologic Evaluation of Anemia – I Adewoyin S. Ademola1* and Ogbenna A. Abiola2 1Department of Haematology and Blood Transfusion, University of Benin Teaching Hospital, PMB 1111, Ugbowo, Benin City, Nigeria 2Department of Haematology and Blood Transfusion, Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria *Corresponding author: Adewoyin S. Ademola, Department of Haematology and Blood Transfusion, University of Benin Teaching Hospital, PMB 1111, Ugbowo, Benin City, Nigeria, Tel: +2347033966347; E-mail: [email protected] Received date: June 20, 2016; Accepted date: July 15, 2016; Published date: July 22, 2016 Copyright: © 2016 Adewoyin AS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. Abstract Anaemia is a feature of many tropical diseases. Anaemia diagnosis therefore remains a crucial intervention among physicians in developing countries. A barrage of laboratory test (anaemic work-up) is usually deployed in differentiating its underlying cause. However, central to anaemia evaluation is the morphology of the red cells and other cell lines. Conventionally, initial laboratory tests include full blood count, reticulocyte count and peripheral blood film (PBF). PBF is often a clinical request, performed by skilled technologist and reported by haematologist/ haematomorphologist. Findings from PBF are reviewed and reported in the light of patient’s clinical history and examination findings.
    [Show full text]
  • Assessment of Splenic Function A
    Assessment of splenic function A. P. N. A. Porto, A. J. J. Lammers, R. J. Bennink, I. J. M. Berge, P. Speelman, J. B. L. Hoekstra To cite this version: A. P. N. A. Porto, A. J. J. Lammers, R. J. Bennink, I. J. M. Berge, P. Speelman, et al.. Assessment of splenic function. European Journal of Clinical Microbiology and Infectious Diseases, Springer Verlag, 2010, 29 (12), pp.1465-1473. 10.1007/s10096-010-1049-1. hal-00624509 HAL Id: hal-00624509 https://hal.archives-ouvertes.fr/hal-00624509 Submitted on 19 Sep 2011 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Manuscript Click here to download Manuscript: Review Assessment of Slenic Function.doc Click here to view linked References 1 2 3 4 Title-page. 5 6 7 8 Title: Assessment of splenic function 9 10 11 Authors: A.P.N.A. de Porto1, A.J.J. Lammers1, R.J. Bennink2, I.J.M. ten Berge3, P. Speelman1, 12 4 13 J.B.L. Hoekstra . 14 15 16 Affiliations 17 18 1: Department of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Center, 19 Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands.
    [Show full text]
  • Maternal-Newborn Nursing Demystified Downloaded by [ Faculty of Nursing, Chiangmai University 5.62.156.86] at [07/18/16]
    Downloaded by [ Faculty of Nursing, Chiangmai University 5.62.156.86] at [07/18/16]. Copyright © McGraw-Hill Global Education Holdings, LLC. Not to be redistributed or modified in any way without permission. Downloaded by [ Faculty of Nursing, Chiangmai University 5.62.156.86] at [07/18/16]. Copyright © McGraw-Hill Global Education Holdings, LLC. Not to be redistributed or modified in any way without permission. Maternal-Newborn Nursing Demystified Downloaded by [ Faculty of Nursing, Chiangmai University 5.62.156.86] at [07/18/16]. Copyright © McGraw-Hill Global Education Holdings, LLC. Not to be redistributed or modified in any way without permission. Notice Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The author and the publisher of this work have checked with sources believed to be reliable in their efforts to provide informa- tion that is complete and generally in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the author nor the publisher nor any other party who has been involved in the preparation or publi- cation of this work warrants that the information contained herein is in every respect accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work. Readers are encouraged to confirm the information contained herein with other sources. For example and in particular, readers are advised to check the product information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.
    [Show full text]